{"gao_id": "GAO-16-432", "published": "2016-05-16T12:00:00Z", "released": "2016-06-15T08:00:00Z", "summary": "", "title": "Medical Product Oversight: FDA Needs More Strategic Planning to Guide Its Scientific Initiatives", "topics": ["Product safety", "Agency missions", "Medical research", "Health Care", "Regulatory agencies", "Science and technology", "Medical products", "Safety regulation", "Strategic planning", "Product evaluation", "Internal controls"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-16-432", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-16-432-highlights.pdf"}, {"title": "Full Report (50 pages)", "url": "https://www.gao.gov/assets/gao-16-432.pdf"}, {"title": "Accessible PDF (58 pages)", "url": "https://www.gao.gov/assets/680/677228.pdf"}]}